Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics

被引:186
作者
Tang, Su-Ni [1 ]
Fu, Junsheng [2 ]
Nall, Dara [2 ]
Rodova, Mariana [1 ]
Shankar, Sharmila [2 ]
Srivastava, Rakesh K. [1 ]
机构
[1] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut & Med, Ctr Canc, Kansas City, KS 66160 USA
[2] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Ctr Canc, Kansas City, KS 66160 USA
基金
美国国家卫生研究院;
关键词
RNAi; cancer stem cells; pancreatic cancer; pluripotency maintaining factors; sonic hedgehog pathway; EGCG; epithelial mesenchymal transition; MOUSE MODEL; QUERCETIN; NANOG; DELIVERY; APOPTOSIS; RENEWAL;
D O I
10.1002/ijc.26323
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Activation of the sonic hedgehog (SHh) pathway is required for the growth of numerous tissues and organs and recent evidence indicates that this pathway is often recruited to stimulate growth of cancer stem cells (CSCs) and to orchestrate the reprogramming of cancer cells via epithelial mesenchymal transition (EMT). The objectives of this study were to examine the molecular mechanisms by which (-)-epigallocatechin-3-gallate (EGCG), an active compound in green tea, inhibits self-renewal capacity of pancreatic CSCs and synergizes with quercetin, a major polyphenol and flavonoid commonly detected in many fruits and vegetables. Our data demonstrated that EGCG inhibited the expression of pluripotency maintaining transcription factors (Nanog, c-Myc and Oct-4) and self-renewal capacity of pancreatic CSCs. Inhibition of Nanog by shRNA enhanced the inhibitory effects of EGCG on self-renewal capacity of CSCs. EGCG inhibited cell proliferation and induced apoptosis by inhibiting the expression of Bcl-2 and XIAP and activating caspase-3. Interestingly, EGCG also inhibited the components of SHh pathway (smoothened, patched, Gli1 and Gli2) and Gli transcriptional activity. Furthermore, EGCG inhibited EMT by inhibiting the expression of Snail, Slug and ZEB1, and TCF/LEF transcriptional activity, which correlated with significantly reduced CSC's migration and invasion, suggesting the blockade of signaling involved in early metastasis. Furthermore, combination of quercetin with EGCG had synergistic inhibitory effects on self-renewal capacity of CSCs through attenuation of TCF/LEF and Gli activities. Since aberrant SHh signaling occurs in pancreatic tumorigenesis, therapeutics that target SHh pathway may improve the outcomes of patients with pancreatic cancer by targeting CSCs.
引用
收藏
页码:30 / 40
页数:11
相关论文
共 45 条
[1]  
[Anonymous], PLOS ONE
[2]   Expression of Pluripotent Stem Cell Reprogramming Factors by Prostate Tumor Initiating Cells [J].
Bae, Kyung-Mi ;
Su, Zhen ;
Frye, Carole ;
McClellan, Steve ;
Allan, Robert W. ;
Andrejewski, Joseph T. ;
Kelley, Vicky ;
Jorgensen, Marda ;
Steindler, Dennis A. ;
Vieweg, Johannes ;
Siemann, Dietmar W. .
JOURNAL OF UROLOGY, 2010, 183 (05) :2045-2053
[3]   Tissue repair and stem cell renewal in carcinogenesis [J].
Beachy, PA ;
Karhadkar, SS ;
Berman, DM .
NATURE, 2004, 432 (7015) :324-331
[4]   Nanog:: A new recruit to the embryonic stem cell orchestra [J].
Cavaleri, F ;
Schöler, HR .
CELL, 2003, 113 (05) :551-552
[5]   Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells [J].
Chambers, I ;
Colby, D ;
Robertson, M ;
Nichols, J ;
Lee, S ;
Tweedie, S ;
Smith, A .
CELL, 2003, 113 (05) :643-655
[6]   Sonic Hedgehog Expression Correlates With Distant Metastasis in Pancreatic Adenocarcinoma [J].
Dai, Juntao ;
Ai, Kaixing ;
Du, Yilong ;
Chen, Guorong .
PANCREAS, 2011, 40 (02) :233-236
[7]   Lysosomal trafficking of β-catenin induced by the tea polyphenol epigallocatechin-3-gallate [J].
Dashwood, WM ;
Carter, O ;
Al-Fageeh, M ;
Li, QJ ;
Dashwood, RH .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2005, 591 (1-2) :161-172
[8]  
Duraj J, 2005, NEOPLASMA, V52, P273
[9]   Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer [J].
Feldmann, G. ;
Habbe, N. ;
Dhara, S. ;
Bisht, S. ;
Alvarez, H. ;
Fendrich, V. ;
Beaty, R. ;
Mullendore, M. ;
Karikari, C. ;
Bardeesy, N. ;
Ouellette, M. M. ;
Yu, W. ;
Maitra, A. .
GUT, 2008, 57 (10) :1420-1430
[10]   Transcription factor AP-2-γ is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors [J].
Hoei-Hansen, CE ;
Nielsen, JE ;
Almstrup, K ;
Sonne, SB ;
Graem, N ;
Skakkebaek, NE ;
Leffers, H ;
Meyts, ERD .
CLINICAL CANCER RESEARCH, 2004, 10 (24) :8521-8530